Discover 2,442 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,442
Active & Responsive
Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS)
for
Neck Pain
Location: Bethesda MD
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
Sex: All
Age: 18 - 65
Code: NCT06214949
Recruiting
Active & Responsive
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
for
Heart Failure With Reduced Ejection Fraction,
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 18 - 70+
Code: NCT06299436
Recruiting
Active & Responsive
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Rimouski, Boston MA, New Haven CT, Quebec,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase3, Recruiting
Active & Responsive
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
for
Posttraumatic Stress Disorder
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 21+
Code: NCT06989957
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Quebec, Chicoutimi, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase3, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Boston MA, Quebec, Washington D.C. DC, Ottawa,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06744920
Phase3, Recruiting
Active & Responsive
Identification and Validation of Epigenetic Biomarkers of PMDD
for
PMDD, Premenstrual Dysphoric Disorder (PMDD),
Location: Baltimore MD
Sponsor: Johns Hopkins University
Sex: Female
Age: 18 - 50
Code: NCT06771583
Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
for
Chronic Migraine
Location: Waltham MA, Westborough MA, New Haven CT,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018713
Phase3, Recruiting
Active & Responsive
A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation
for
AML, Myelodysplastic Syndromes, ALL, Adult
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,